Effect of eicosapentaenoic acid/docosahexaenoic acid on coronary high-intensity plaques detected with non-contrast T1-weighted imaging (the AQUAMARINE EPA/DHA study): study protocol for a randomized controlled trial

BACKGROUND: Despite the success of HMG-CoA reductase inhibitor (statin) therapy in reducing atherosclerotic cardiovascular events, a residual risk for cardiovascular events in patients with coronary artery disease (CAD) remains. Long-chain n-3 polyunsaturated fatty acids (LC n-3 PUFAs), especially e...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakao, Kazuhiro, Noguchi, Teruo, Asaumi, Yasuhide, Morita, Yoshiaki, Kanaya, Tomoaki, Fujino, Masashi, Hosoda, Hayato, Yoneda, Shuichi, Kawakami, Shoji, Nagai, Toshiyuki, Nishihira, Kensaku, Nakashima, Takahiro, Kumasaka, Reon, Arakawa, Tetsuo, Otsuka, Fumiyuki, Nakanishi, Michio, Kataoka, Yu, Tahara, Yoshio, Goto, Yoichi, Yamamoto, Haruko, Hamasaki, Toshimitsu, Yasuda, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759279/
https://www.ncbi.nlm.nih.gov/pubmed/29310688
http://dx.doi.org/10.1186/s13063-017-2353-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759279/
https://www.ncbi.nlm.nih.gov/pubmed/29310688
http://dx.doi.org/10.1186/s13063-017-2353-1

Ejemplares similares